Newsroom

Sorted by: Latest

-

Western Alliance Bank Supports OnQ With $7.5 Million Asset-Based Line of Credit

NEW YORK--(BUSINESS WIRE)--Western Alliance Bank today announced that OnQ, the leading retail display company, has secured an enhanced credit facility with the bank’s Asset-Based Lending Group. Western Alliance Bank is supporting OnQ by providing a $7.5 million asset-based line of credit and customized treasury management solutions to support the company’s current growth trajectory. The line of credit provides OnQ with flexibility as it scales its platform to serve a growing base of global reta...
-

Citi Trends, Inc. Announces Board Transition, Finance Committee Leadership Update, and Extension of Cooperation Agreement with Fund 1

SAVANNAH, Ga.--(BUSINESS WIRE)--Citi Trends, Inc. (NASDAQ: CTRN) (“CITITRENDS” or the “Company”), a leading off-price value retailer of apparel, accessories and home trends primarily for Black families in the United States, today announced a series of governance and shareholder-related updates, including a Board transition, Finance Committee leadership change, and the extension of its cooperation agreement with Fund 1 Investments, LLC (“Fund 1”). The Company announced that Wes Calvert has depar...
-

Assured Guaranty Ltd. Raises Quarterly Dividend by 12% to $0.38 per Common Share

HAMILTON, Bermuda--(BUSINESS WIRE)--Assured Guaranty Ltd. (NYSE:AGO) today declared a quarterly dividend of $0.38 per common share, an increase of 12% from the quarterly dividend of $0.34 per common share that was declared on November 5, 2025. The dividend is payable on March 20, 2026 to shareholders of record at the close of business on March 6, 2026. Assured Guaranty Ltd. is a publicly traded (NYSE: AGO), Bermuda-based holding company. Through its subsidiaries, Assured Guaranty provides credi...
-

DNOW Reports Fourth Quarter and Full-Year 2025 Results

HOUSTON--(BUSINESS WIRE)--DNOW Reports Fourth Quarter and Full-Year 2025 Results...
-

ヨルテック・セラピューティクス、α1-アンチトリプシン欠乏症治療用のYOLT-202において良好な中間データを発表

上海--(BUSINESS WIRE)--(ビジネスワイヤ) -- 生体内ゲノム編集療法を開発している臨床後期段階のバイオテクノロジー企業であるヨルテック・セラピューティクスは、α1-アンチトリプシン欠乏症(AATD)の治療を目的とする同社の開発中生体内塩基編集療法YOLT-202について、医師主導治験(IIT)における中間データが良好であることを発表しました。35mgおよび45mgの用量レベルで投与された評価対象患者において、安全性および忍容性が良好であることに加え、AAT値の意義のある上昇が示されました。 「今回の中間結果は、ヨルテックにとっても、重症AATDとともに生きる患者にとっても、重要かつ意義深いマイルストーンとなるものです。本治験で観察された機能的AAT値の迅速かつ力強い、そして用量依存的な上昇は、特にPiZZ遺伝子型を持つ患者において顕著であり、生体内塩基編集が単回投与による治療アプローチとして持つ変革的な可能性を裏付けています」と、ヨルテック・セラピューティクスの創設者兼最高経営責任者(CEO)であるYuxuan Wu医師は述べています。「これまでに確認されている良...
-

Telekom Srbija Group Announces Platinum Sponsorship of EXPO 2027 Belgrade

BELGRADE, Serbia--(BUSINESS WIRE)--Telekom Srbija Group today announced its Platinum Sponsorship of EXPO 2027 Belgrade, marking a major milestone in the company’s continued leadership in digital innovation and infrastructure across the region. As a Platinum Sponsor, Telekom Srbija will play a central role in delivering the digital backbone of EXPO 2027, powering connectivity and enabling the state-of-the-art technological infrastructure that will support one of the largest international events...
-

AdvanSix Announces Fourth Quarter and Full Year 2025 Financial Results

PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix Announces Fourth Quarter And Full Year 2025 Financial Results...
-

NATIXIS UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...
-

AngloGold Ashanti Q4 and Year Ended 31 December 2025 Earnings Release and Dividend Declaration

LONDON & DENVER & JOHANNESBURG--(BUSINESS WIRE)--AngloGold Ashanti plc’s(2) delivered record free cash flow*(5) of $2.9bn in 2025 on strong production growth, continued cost discipline and a higher average gold price received per ounce*. The Company announced an interim dividend of $875m for Q4 2025, taking the total payout declared for 2025 to $1.8bn, the highest ever. AngloGold Ashanti again achieved guidance on gold production and sustaining capital expenditure*, as it continues to build a t...
-

NATIXIS UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...